Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Dec 24 | ATYR aTyr Pharma | Stock Option Common Stock | Grant | Acquire A | No | No | 3.29 | 100,000 | 329.00 k | 100,000 |
15 Apr 24 | NBIX Neurocrine Biosciences | Common Stock | Sell | Dispose S | No | Yes | 133.3646 | 12,587 | 1.68 mm | 40,778 |
15 Apr 24 | NBIX Neurocrine Biosciences | Common Stock | Option exercise | Acquire M | No | No | 81.05 | 12,587 | 1.02 mm | 53,365 |
15 Apr 24 | NBIX Neurocrine Biosciences | Common Stock | Sell | Dispose S | No | Yes | 133.3646 | 7,231 | 964.36 k | 40,778 |
15 Apr 24 | NBIX Neurocrine Biosciences | Common Stock | Option exercise | Acquire M | No | No | 81.49 | 7,231 | 589.25 k | 48,009 |
15 Apr 24 | NBIX Neurocrine Biosciences | NQSO Common Stock | Option exercise | Dispose M | No | No | 81.05 | 12,587 | 1.02 mm | 0 |
15 Apr 24 | NBIX Neurocrine Biosciences | NQSO Common Stock | Option exercise | Dispose M | No | No | 81.49 | 7,231 | 589.25 k | 26,292 |
14 Mar 24 | NBIX Neurocrine Biosciences | Common Stock | Sell | Dispose S | No | Yes | 139.3789 | 69,521 | 9.69 mm | 40,778 |
14 Mar 24 | NBIX Neurocrine Biosciences | Common Stock | Option exercise | Acquire M | No | No | 81.05 | 69,521 | 5.63 mm | 110,299 |
14 Mar 24 | NBIX Neurocrine Biosciences | Common Stock | Sell | Dispose S | No | Yes | 139.3789 | 5,479 | 763.66 k | 40,778 |